39a Bombay St, Ngaio, Wellington 6035, NZ

+64221998782

©2019 by Dr. Keryn Johnson (THE QUANTUM BIOLOGIST). Proudly created with Wix.com

Reports

IRL-R--1672 Confidential to IRL and Crop & Food Research - Document version __001 , Cold functioning enzymes : isolation and characterisation of transglutaminase from Hoki liver and potential applications 2004 Johnson K.D. Learmonth A. Sommer-Knudsen J.

IRL-R--1738 Confidential (C) to IRL and Crop & Food Research - Project No. 35011902 - On cover: Document version __001 - Sent to Information Service 25/07/2005 Cold functioning enzymes : Hoki liver transglutaminase extraction and partial characterisation 2005 Johnson K.D. Learmonth A.

IRL-R--1684 Confidential (C) to IRL and Invitrogen Life Technologies - Project No. 50155.02 - On cover: Document version __002 - Sent to Information Service 04/05/2005 Lactoferrin binding study - 3 2005 Johnson K.D. Learmonth A. Sommer-Knudsen J.

IRL-R--1774 Final deliverable report. Confidential to IRL and client (French Maid Foods). Document is incorrectly styled as IRL-R--1174. Diastase enzyme determination 2005 Johnson K.D.

IRL-R--1916 Confidential (C) to IRL and Crop & Food Research - Document version __001 - Project number: 35011902 Preparation of Hoki liver TG and analysis of its commercial potential. Report 3: 10.01.05 to 20.12.06 2007 Johnson K.D.

IRL-R--1934 Confidential to Meat and Livestock Australia Biologically active glycoconjugate products from red meat processing. Phase II. Part A The validation of the wound healing potential of [beta]crystallin B2 and development of this protein into a product that promotes wound healing. Report for milestone 4. Identification of alternative sources of beta B2 crystallin 2007 Johnson K.D.

IRL-R--1946 Confidential - No copies held by Information Service Undertake purification from alternative source Project 35019802. Milestone report 2007 Johnson K.D.

IRL-R--1944 Confidential - No copies held by Information Service Biodiscovery of additional wound healing glycopeptides 2007 Johnson K.D.

IRL-R--1943 Confidential - No copies held by Information Service Validation of wound healing potential of beta B2 crystallin 2007 Johnson K.D.

IRL-R--1942 Confidential - No copies held by Information Service Undertake validation of wound healing potential of other eye derived crystallins 2007 Johnson K.D.

IRL-R--1929 Confidential to IRL and Hokotehi Moriori Trust Bio-actives from marine invertebrates. Final report 2007 Vyssotski M. Svetashev V. MacKenzie A.D. Nekrasov E. Johnson K.D. Catchpole O.J.; Grey J.B.; Tauwhare S.E.K.

IRL-R--1924 Confidential - No copies held by Information Service Primary sequence analysis of SAT I and SAT IV 2007 Johnson K.D.

IRL-R--1968 Confidential to Meat Biologics Consortium - Project No. 35010104 Meat Biologics Consortium Project No. 7. Report for Milestone 1. Comparison of SAT I activity in various spleen microsome extracts and a novel approach to affinity matrix synthesis and SAT I assay using HPLC 2007 Vasudevamurthy M Johnson K.D.

IRL-R--1974 Confidential to Meat Biologics Consortium - Project No. 35010104 Meat Biologics Consortium Project No. 7. Report for milestone 2. Annual Project Review 2007 Vasudevamurthy M Johnson K.D.

IRL-R--1950 Full title to be advised Best practice recovery of bovine eye ?..... and outline of large scale production 2007 Johnson K.D.

IRL-R--2007 Confidential to client. - 12 refs; 10 figs; 4 tables Development of novel purification and stabilization methods for ovine and bovine SAT I : Meat Biologics Consortium project no. 7: Meat-derived enzymes in glycobiology : report for milestone 3 2007 Vasudevamurthy M. Johnson K.D.

Confidential to Meat Biologics Consortium - Project No. 35010104 Meat Biologics Consortium Project No. 7. Report for milestone 5. Synthesis and Isolation of Ganglioside GM3 using calf spleen microsomes 2008 Vasudevamurthy M. Johnson K.D.

IRL-R--2270Cold functioning enzymes. Development of transglutaminase assay and application for the purification of transglutaminase from salmon hearts. Report for the period: 01.01.08 to 30.06.08 2008 Hubl U. Johnson K.D.

IRL-R--1578Anti-angiogenic bioactive lipids. Annual report 2003-4 2004 Vyssotski M. Johnson K.D. MacKenzie A.D.

IRL-R--1590-1595 Report numbers: 1590-1595 provided to K. Johnson but no title has been provided No title provided 2004 Johnson K.D. Sommer-Knudsen J.

IRL-R--2282 Report for Milestone 11 & 12: To undertake a comparative study in a delayed healing model.

Confidential to Meat and Livestock Australia Biologically active glycoconjugate products from red meat processing – phase II. Part A: The validation of the wound healing potential of beta crystallin B2 and development of this protein into a product that promotes wound healing. 2008 Johnson K.D. Vasudevamurthy M.


IRL-R--2281 No copy supplied - Confidential Develoin an ostepath arthritis rat modelpment of a joint care nutriceutal report for miletones 3 & 4 : validation of oral availability. Part A. 2008 Johnson K.D. Sun C.


IRL-R--2406 Confidential to Schering Plough Analysis of unknown particles from vaccine production process. Final deliverable report (Version 1) 2010 Johnson K.D.

IRL-R--2406 Confidential to Schering Plough Analysis of unknown particles from vaccine production process. Final deliverable report (Version 1) 2010 Johnson K.D.

IRL-R--2470 Confidential to IRL and client Meat and Livestock Australia (MLA) Protein and peptide wound dressing preparations 2010 Johnson K.D. Rendle P.M. Anderson J.

IRL-R--2474 Strictly Confidential to Project Team and Client-copies to remain with IRL authors and client Transformational dairy programme. Year 2 milestone 2 Protein lipid interactions 2010 Johnson K.D. Sun C.


IRL-R--2479 To Client (Meat and Livestock Australia) and IRL

Requested copy from 1st author 14 Jan 2014 (CJ) Preclinical testing of protein and peptide wound dressing prototypes in pig pilot wound healing stud 2010 Johnson K.D. Anderson J.

IRL-R--2498 Highly ccnfidential - not to go outside of the project teams in IRL or Fonterra. Do not request again. Protein lipid interactions. Final report 2011 Johnson K.D. Sun C

IRL-R--2501 Confidential to Honey Labs Limited and IRL Testing of three Kanuka honey samples for pH; antimicrobial activity; peroxidase and catalase activity; and content of methylglyoxal abscisic acid and 4-methoxybenzoic acid 2011 Mitchell K.A. Johnson K.D. Zhang S. Ryan J. Catchpole O.J.

IRL-R--2529 To client and IRL staff immediately involved in the project. Off limits to all others

Milestone 2. Protein lipid interactions Final report 2011 Johnson K.D. Sun C.

IRL-R--2533 Strictly Confidential to Project Team and Fonterra Transformational Dairy Programme. Final Report Phase 2 2011 MacKenzie A.D. Johnson K.D. Sun C. Scott D.M. Webby R.F.

IRL-R--2552 Confidential to IRL immediate team and client

Characterisation of manuka honey proteins and phenolic. Part C Combo dressing 2011 Kim S. Johnson K.D.

IRL-R--2569 Confidential to Synlait

Requested copy from 1st author 16 Jan 2014 (CJ) ELISA analysis of Synlait milk samples 2012 Hubl U. Johnson K.D.

IRL-R--2572 Confidential to client: Atlas South Sea Pearl Ltd Development of value added extracts from pearl oyster shells (Pinctada maxima) 2012 Billakanti J. Johnson K.D. Sharp M. Baxter N.I.

IRL-R--2576 Confidential to Meat and Livestock Australia. Requested copy from 1st author 14 Jan 2014 (CJ) Development of a pet food joint care nutraceutical 2012 Johnson KD

IRL-R--2577 Confidential to ManukaMed Watson & Son. Requested copy from 1st author 14 Jan 2014 (CJ) Purification of apalbumin (major royal jelly proteins) from royal jelly 2012 Johnson K.D. Sun C.

IRL-R--2578 Confidential to client Watson & Son. Requested copy from 1st author 14 Jan 2014 (CJ) Modification of major royal jelly proteins and milestone 5 report : analysis of modification formation 2012 Johnson K.D. Hubl U.

IRL-R--2579 Confidential to client Watson & Son. Requested copy from 1st author 14 Jan 2014 (CJ) Milestone 3 report : bioassays 2012 Johnson K.D. Sun C. Hubl U.

IRL-R--2580 Confidential to client Watson & Son. Requested copy from 1st author 14 Jan 2014 (CJ) Milestone 4 report : mass spectral analysis 2012 Johnson K.D. Sun C. Hubl U.

IRL-R--2589 Synlait Determination of Melatonin levels in Synlait milk samples 2012 Hubl U. Johnson K.D.

IRL-R--2618 Confidential to IRL and Meat and Livestock Australia. Requested copy from 1st author 14 Jan 2014 (CJ) Report for milestone 3 and 4 : validation of activity and reporting the outcome of the validation study 2012 Johnson K.D.

IRL-R--2650 Confidential to Tru2U and IRL. Requested copy from 1st author 16 Jan 2014 (CJ) Analysis of melatonin in cherry extracts 2012 Hubl U. Johnson K.D.

CI-R--0004 Confidential to Client and IRL team involved in project. Requested copy from 1st author 26 Jun 2013 (CJ) To characterize Manuka honey protein and phenolic anti-inflammatory compounds 2013 Johnson K.D. Billakanti J.M. Zhang S. Webby R.F. Mitchell K.A. Hubl U.; Sun C.

CI-R--0012 Confidential to Callaghan Innovation and Value Proteins Limited Evaluate methods to extract protein from bone to increase the protein content of meat and bone meal 2013 Billakanti J.M. Johnson K.D. Sharp M.

CI-R--0033 Confidential to CIRL and Value Proteins Limited Evaluate methods to extract protein from bone to increase the protein content of meat and bone meal 2013 Billakanti J.M. Johnson K.D. Sharp M.

CI-R--0035 Confidential client. Requested copy from 1st author 16 Jan 2014 (CJ) Bioavailability of peptides in Manuka honey 2013 Hubl U. Billakanti J.M. Sun C. Johnson K.D.

CI-R--0037 Confidential to IBT - note: document shows This is a controlled document. Unauthorised printing distribution or copying is PROHIBITED High value lipids : BALB/c mouse dextrin induced inflammatory bowel disease model and evaluation of CAEP for anti inflammatory activity 2013 Vyssotski M. Williams D.B.G. MacKenzie A.D. Tallon S.J. Hubl U. Johnson K.D.

CI-R--0066 Confidentiality: Callaghan Innovation. Requested copy from 1st author 16 Jan 2014 (CJ) Exploring methods to extract added-value bioactive compounds from salmon roe 2013 Billakanti J.M. Fenton K. Vyssotski M. Johnson K.D.

CI-R--0075 Confidential to Callaghan Innovation AgResearch Plant & Food Research Scion Synlait Milk Ltd and Value Proteins Ltd Executive summary of DAF and MBM value addition BPA 05 2014 Billakanti J.M. Johnson K.D. Ryan J. Hubl U. Sun C. MacKenzie A.D.; Bloor S.J.; Lagutin K.; Fenton K.; Grey J.B.; Webby R.F.; Sharp M.

CI-R--0077 Confidential to ManukaMed and Callaghan Innovation Honey fractionation and human leukocyte elastase inhibition 2013 Johnson K.D. Stewart D.M. Williams D.B.G. Hubl U.

CI-R--0078 Confidential to ManukaMed and Callaghan Innovation Apisimin and MGO modified apisimin and 13-720M manuka honey fractionation and cathepsin B inhibition 2013 Johnson K.D. Sun C. Billakanti J.M. Stewart D.M. Williams D.B.G.

CI-R--0079 Strictly Confidential (access to Project Team/GM/CEO and Client). Manuka honey - Watson and Son / ManukaMed Full length apisimin and recombinant apisimin with and without MGO modification and phagocytosis bioassays 2014 Johnson K.D. Billakanti J.M. Stewart D.M. Williams D.B.G.

CI-R--0080 Strictly Confidential (access to Project Team/GM/CEO and Client). ManukaMed / Watson and Son Full length apisimin and MGO modified apisimin : summary report 2014 Johnson K.D. Stewart D.M. Williams D.B.G.

CI-R--0092 Highly confidential to client and project team Honey fractionation and cathepsin B inhibition 2014 Johnson K.D. Billakanti J.M. Sun C. Stewart M. Williams D.B.G.

CI-R--0093 Confidential to ManukaMed Ltd and Callaghan Innovation Honey fractionation and human leukocyte elastase inhibition : interim delivery report 2013 Johnson K.D. Billakanti J.M. Hubl U. Stewart M. Williams D.B.G.

CI-R--0099 Callaghan Innovation and Manuka Med Ltd Manuka med-partial MRJP-3 protein 2014 Billakanti J.M. Zhang S. Johnson K.D. Steward M.

CI-R--0102 Callaghan Innovation and Watson & Son/Manuka Med Limited Production of recombinant MRJP3 fragment : 100-200 mg scale 2014 Billakanti J.M. Zhang S. Johnson K.D. Steward M. Ryan J. Report for Milestone 3 & 4: Validation of oral bioavailability in a osteoarthritis rat model. Confidential to Meat and Livestock Australia. Some handwritten notes throughout Biologically active glycoconjugate products from red meat processing : phase II. Part A: Development of a joint care nutraceutical 2008 Johnson K.D. Sun C.

CI-R--0114 Public version for Meat & Livestock Australia. The original full length report was reported to MLA in May 2012. This new report May 2014 is a Summary report of the May 2012 report Biologically active glycoconjugate product from red meat processing : Phase III. Development of a pet food joint care nutraceutical 2014 Johnson K.D.

CI-R--0146 Confidential to BPA partners and Cedenco Cedenco business opportunity assessment 2014 Catchpole O.J. Johnson K.D. Tallon S.J.

CI-R--0147 Bioresource Processing Alliance Project Number: BPA02 Overview of water separation and drying technologies 2014 Dyer P.J. Tallon S.J. Johnson K.D.

CI-R--0272 Confidential to BPA partners BPA 120 : Chop Shop 2015 Johnson K.D. Tallon S.J.

CI-R--0278 Confidentiality: Bioresource Processing Alliance partners. Cedenco Recovery of additional value from Cedenco vegetable streams 2015 Tallon S.J. Johnson K.D.

8808 A AS kA Functional comparison of ovine and porcine trypsins 2002 Vol.131 (3) p.423-431 Johnson K.D. (IRL) Clark A. Marshall S.N.JOHNSONK;MARSHALLS Comparative biochemistry and physiology. Biochemistry & molecular biology 2001/2002 3A

11184 A XX K Synthesis and bioactivity of sulfated di- tri- and tetrasaccharide repeat units of chondroitin sulfate ComBio (2002 : Sydney Australia) 2002 Zubkova O.V. Benjes P.A. Johnson K.D. Slim G.C.

12066 A AS JA functional comparison of ovine and porcine chymotrypsins 2005 Vol.48 no.3 p.311-319 Johnson K.D. Marshall S. Clark A. JOHNSON K New Zealand journal of agricultural research 2005/2006 3A

13675 A XX KThe potential of a novel grapefruit extract in would healing European Tissue Repair Society. Annual meeting (17th : 2007 : Southampton UK) 2007 Conference presentation Johnson K.D. 

14006 A XX K Red meat bioactives Meat and Livestock Australia. Bioactives workshop (2008 : Brisbane) 2008 Conference presentation Johnson K.D. JOHNSON K 2007/2008 3G

14007 A XX KThe potential of a novel grapefruit extract in wound healing NZBio conference (2008 : Auckland) 2008 Conference presentation Johnson K.D. JOHNSON K 2007/2008 3G

14266 A AS Apoptotic effect of peptides produced by elastase I hydrolysis of bone proteoglycan extract 2008 p.402-403 McLaughlin R. Johnson K.D. Harper J. Vasudevamurthy M. MCLAUGHLIN R; JOHNSON K; VASUDEVAMURTHY M Peptides 2007/2008 3A

14691 A AS J 10.1016/j.biomaterials.2010.02.025 01429612A functional extracellular matrix biomaterial derived from ovine forestomach. 2010 Vol.31 no.16 p.4517-4529 Lun S. Irvine S.M. Johnson K.D. Fisher N.J. Floden E.W. McLaughlin R.; Vasudevamurthy M. JOHNSON K; MCLAUGHLIN R; VASUDEVAMURTHY M Biomaterials 2009/2010 3A

14875 A AS J[(1S)-1-(9-Deazaadenin-9-yl)-14-dideoxy-14-imino-5- methylthio-D-ribitol Bishydrochloride]2 monohydrate. Structure DFT energy and ligand docking results of a potent Methylthioadenosine phosphorylase inhibitor found in different molecular configurations 2010 Submitted paper Gainsford G.J. Evans G.B. Johnson K.D. Seth M. GAINSFORD G; EVANS G; JOHNSON K Acta crystallographica. Section C Crystal structure communications 2010/2011 3A

15414 A AS J 10.1089/acm.2011.0685 10755535 New Zealand Kanuka Honey has high levels of methylglyoxal and antimicrobial activity 2012 Vol.18(3) p.203-204 Holt S. Johnson K.D. Ryan J. Catchpole O.J. Zhang S. Mitchell K.A. JOHNSON K; RYAN J; CATCHPOLE O; ZHANG S; MITCHELL K Journal of alternative and complementary medicine 2011/2012 3A

15748 XX KPEE-G : novel dendrimers for pharmaceutical applications Biennial International Symposium on Biological Applications of Dendrimers (3rd : 2012 : Toledo Spain) 2012 Conference presentation (Poster) Rendle P.M. Toms S.M. Carnachan S.M. Johnson K.D. Johnston K.A. RENDLE P; TOMS S; CARNACHAN S; JOHNSON K; JOHNSTON K 2012/2013 3G 16329 A AS J

10.1371/journal.pone.0094206


19326203A new assay for determining ganglioside sialyltransferase activities lactosylceramide-23-sialyltransferase (SAT I) and monosialylganglioside-23- sialyltransferase (SAT IV) 2014 Vol.9 no.4 article no. e94206 Sun C. Hubl U. Hoefakker P.C.M. Vasudevamurthy M.K. Johnson K.D. SUNC; HUBL U; HOEFAKKER P; JOHNSON K PLoS ONE3A 


Callaghan Innovation report 0612. ASSAY DEVELOPMENT AND VALIDATION FOR GSM SAMPLES. Cynthia Sun Keryn Johnson Ulrike Hubl and Andrew MacKenzie. J02462 No 2018/19.

Callaghan Innovation report 0600 Protein and Carbohydrate Analysis in Deer Milk. Keryn Johnson Ulrike Hubl and Cynthia Sun. J02350 No 2018/19.


Callaghan Innovation report 0588. Mussel Separations and Processing: Membrane Selection and Pilot Trials. Peter Dyer Andrew MacKenzie Dawn Scott Keryn Johnson John Grey and Tina Fenton. 245 No 2017/18

Callaghan Innovation report 0571. Production of fish maw powder for encapsulation. Keryn Johnson. J01624 No 2017/18

Callaghan Innovation report 0567. Synthase Biotech SOW4 Stage 1: Evaluation of fermentation conditions in 1-L bioreactors for AOS production from recombinant E. coli. Kat Allikian Keryn Johnson. J01711 No 2017/18

Callaghan Innovation report 0564. ANALYSIS OF COX-2 AND PROTEASE ACTIVITIES OF 6 GSM POWDER SAMPLES. Cynthia Sun Keryn Johnson. J02116 No 2017/18

Callaghan Innovation report 0530. Collagen analysis of fish maw. Keryn Johnson J01624 No 2017/18


Callaghan Innovation report 0514. Optimisation of the enzymatic hydrolysis process for GSM with functionality assessment. Cynthia Sun Keryn Johnson Rosemary Webby Ulrike Hubl Andrew MacKenzie Kirill Lagutin Dawn Scott. 95217307 No 2017/18

Callaghan Innovation report 0498. LITERATURE REVIEW INVESTIGATING TURBIDITY IN CALF SERUMS. Keryn Johnson. 95226700 No 2017/18


Callaghan Innovation report 0477. Lactoferrin Analysis of Infant Formula Powders. Jagan Billakanti Keryn Johnson. No 2017/18

Callaghan Innovation report 0474. Drying and analysis of the solids content of Batavia Biosciences supernatants and comparison with Batch 2 MIS416 processing supernatants Lot No: B1703. Keryn Johnson 95223611 No 2017/18


Callaghan Innovation report 0463. Analysis of Batch 2 MIS416 processing supernatants Lot No: B1703A and comparison to Batch 1 MIS416 processing supernatants Lot No: B1605A. Antonia Miller Keryn Johnson Mikhail Vyssotski. 95223606 No 2016/17

Callaghan Innovation report 0461. Identification of hypoallergenic or antiallergenic molecules in GSM. Cynthia Sun Andrew MacKenzie Rahau Shirazi Dawn Scott and Keryn Johnson. 95217306 No 2016/17

Callaghan Innovation report 0427. Iron Binding Capacity of Synlait LF. J.M. Billakanti Keryn Johnson. No 2016/17

Callaghan Innovation report 0415. Front Face Fluorescence Spectroscopy. Keryn Johnson. 95212127 No 2016/17

Callaghan Innovation report 0393. Continued analysis of MIS416 processing supernatants. Antonia Miller Keryn Johnson Mikhail Vyssotski. 95223602 No 2016/17

Callaghan Innovation report 0374. Determination of iron saturation level of bovine lactoferrin. Ingredia LF. J.M. Billakanti Keryn Johnson. No 2016/17

Callaghan Innovation report 0366. Macromolecule analysis in MIS416 processing supernatants. A. Miller and Keryn Johnson. 95223601 No 2016/17


Callaghan Innovation report No. XXX . Further developments of HDAC inhibition identification. Prepared for Grasslanz. Keryn Johnson Stephen Bloor Andrew MacKenzie Andrew Lewis Martin Ryan and Pauline Calloch. 22/03/2019. Confidential to Grasslanz and to Callaghan Innovation.


CONFERENCES:

11184 A XX K Synthesis and bioactivity of sulfated di- tri- and tetrasaccharide repeat units of chondroitin sulfate ComBio (2002 : Sydney Australia) 2002 Zubkova O.V. Benjes P.A. Johnson K.D. Slim


13675 A XX K The potential of a novel grapefruit extract in would healing European Tissue Repair Society. Annual meeting (17th : 2007 : Southampton UK) 2007 Conference presentation Johnson K.D. JOHNSONK2007/2008 3G


14006 A XX K Red meat bioactives Meat and Livestock Australia. Bioactives workshop (2008 : Brisbane) 2008 Conference presentation Johnson K.D. JOHNSON K 2007/2008 3G


14007 A XX K The potential of a novel grapefruit extract in wound healing NZBio conference (2008 : Auckland) 2008 Conference presentation Johnson K.D. JOHNSON K 2007/2008 3G


15748 XXKPEE-G : novel dendrimers for pharmaceutical applications Biennial International Symposium on Biological Applications of Dendrimers (3rd : 2012 : Toledo Spain) 2012 Conference presentation (Poster) Rendle P.M. Toms S.M. Carnachan S.M. Johnson K.D. Johnston K.A. RENDLE P; TOMS S; CARNACHAN S; JOHNSON K; JOHNSTON K 2012/2013 3G